Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma

NCT03168035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Lymphoma

Interventions

DRUG: NC-4016

Sponsor

NanoCarrier Co., Ltd.

Collaborators

[object Object]